Detalhe da pesquisa
1.
Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats.
Antimicrob Agents Chemother
; 64(9)2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540976
2.
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa.
Biochim Biophys Acta Biomembr
; 1859(10): 1796-1804, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28583831
3.
Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats.
Antibiotics (Basel)
; 9(3)2020 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32138210
4.
Differences in Systemic IgA Reactivity and Circulating Th Subsets in Healthy Volunteers With Specific Microbiota Enterotypes.
Front Immunol
; 10: 341, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30899257
5.
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
Int J Antimicrob Agents
; 54(2): 159-166, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173867